Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 221

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 221
---
)$(1,964,471)$118,498 

The accompanying notes are an integral part of these consolidated financial statements.

F-10

Precigen, Inc. and Subsidiaries

Consolidated Statements of Mezzanine Equity and Shareholders' Equity

Years Ended December 31, 2024, 2023, and 2022 

(Amounts in thousands, except share data)Mezzanine Stock Common StockTreasury StockAdditionalPaid-inCapitalAccumulatedOtherComprehensive(Loss) Income AccumulatedDeficitTotalShareholders'EquitySharesAmountSharesAmountSharesAmountBalances at December 31, 2023— $— 248,919,096 $— 7,479,431 $— $2,084,916 $(1,947)$(1,964,471)$118,498 Stock-based compensation expense— — — — — — 9,471 — — 9,471 Shares issued upon vesting of restricted stock units and for exercises of stock options— — 1,514,394 — (1,514,394)— 346 — — 346 Shares issued for accrued compensation— — 2,170,885 — (2,170,885)— 3,039 — — 3,039 Shares issued as payment for services— — 385,783 — (385,783)— 553 — — 553 Shares issued in public offering, net of issuance costs— — 39,878,939 — (3,408,369)— 30,882 — — 30,882 Net loss— — — — — — — — (126,235)(126,235)Issuance of Series A Preferred Stock79,000 28,218 — — — — — — — — Reclassification of cumulative foreign currency translation adjustments to other income (expense), net— — — — — — — 2,915 — 2,915 Other comprehensive loss— — — — — — — (956)— (956)Balances at December 31, 202479,000 $28,218 292,869,097 $— —